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every year were significantly associated with peripheral eosinophilia in
SSc patients (OR 3.46 (95%CI 1.11-10.73) and 1.16 (95%CI 1.03-1.30),
respectively), while Raynaud’s phenomenon had a significantly negative
correlation with peripheral eosinophilia in SSc (OR 0.27: 95%CI 0.09-
0.84). Other parameters—such as SSc subset, severity of skin tightness,
serology, cytokines (transforming growth factor-b, interleukin-5)—were not
correlated with peripheral eosinophilia.
Conclusion: Peripheral eosinophilia of unknown cause can be detected 1
in 5 SSc patients. The factors associated with peripheral eosinophilia are
longer disease duration and being male while vasculopathy has a nega-
tive association.
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Background: Systemic sclerosis (SSc) is a progressive connective tis-
sue disease of unknown etiology characterized by autoimmune
response and changes in the microvascular system. Although skin fib-
rosis represents the primary element of this disease, patients may
present muscular and/or joint damage. Hand impairment is a major
cause of morbidity and disability in about 90% of SSc patients. The
ADL difficulties are similar to those of patients with rheumatoid arthritis
but SSc patients use a low number of assistive device. In our center
an interdisciplinary research unit composed of rheumatologists, rehabili-
tators, occupational therapists, and design engineers, with the directly
involvement of the SSc patients within the design team, are developing
a design method to prototype ergonomic assistive device personalized
for hands.
Objectives: Evaluate through the 16 grip test which were the most diffi-
cult grips for SSc patients in order to understand what particular changes
we need to focus on more rehabilitative attention. Determine what ADL
can be linked to difficult grips to understand how to work on it. Give
advice and design appropriate customized ergonomic aids.
Methods: 92 patients (79 females and 13 males) with SSc followed by
our tertiary Universitary based Rheumatologic Center have been specifi-
cally evaluated by Hand Rehabilitation Service. The average age of
patients was 56y. The 16 grip test was used to evaluate patients. It
includes 16 different pattern of grip divided into power grip and precision
pinch - Moreover it tests basically two different grip and pinch modalities:
static prehension and dynamic prehension. The score for each grip goes
from 0 to 4 (0=impossible,1=realized with high difficulty, 2=medium diffi-
culty, 3= low difficulty, 4=normal).
Results: 30 patients (32%) had no grip problem, 9 only on the left and
5 on the right hand; 4 patients presented grip difficulty in both hands
with a reduction> 25%. 31 had difficulty in 2 or more grip pattern. The
most interested grips are the monodigital and pluridigital pressure, the
tip to tip pinch, the extension grip in both sexes; the teno-digital in
males and the digito-palmar in females. Over 60% of the grips were
normal; in particular in our patients only few deficiencies in the power
and in the static prehension grips were reported. The most interested
patterns of grips are in the group of precision handling related to the
use of the pads; the extension grip to the difficulty in opening the first
commissure.
Conclusion: Over 60% of the grips were normal.; in particular in our
patients only few deficiencies in the power grips and in the static pre-
hension grips were reported. The most interested patterns of grips are in
the group of precision handling related to the use of the fingertips; the
extension grip to the difficulty in opening the first commissure. The prob-
lems of hand impairment are restricted to a subset of patients around
10-15%. From these results we can obtain useful data to construct our
personalized devices for SSc hands.
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Background: In some patients, Raynaud’s Phenomenon (RP) symptoms
prove resistant to conventional vasodilatory treatment. Thoracic sympathec-
tomy is shown to be effective as treatment of RP, but is associated with
surgical burden. During this procedure, the sympathetic nerve traversing
to the upper extremity is dissected, subsequently leading to vasodilatation.
In our centre, single-port thoracoscopic sympathicotomy (SPTS) has been
developed, a minimally invasive technique, extensively limiting surgical
burden. [1]
Objectives: To evaluate SPTS feasibility and efficacy after one month in
patients with treatment resistant RP.
Methods: In this study RP patients were their own controls, as they
received an unilaterally left sided sympathicotomy. The effects of the
SPTS was assessed at baseline and one month after the procedure.
Perfusion of the hand was assessed using a cooling and recovery proce-
dure, and laser speckle contrast analysis (LASCA) at room temperature
of 23 degrees Celsius. The number and duration of RP attacks was
reported over a two week period prior to reassessment by standard
questionnaire.
Results: Eight patients were included in the study, 6 male/2 female, with
a median (IQR) age of 45.2 (30.2–55.3) years, body mass index of 23.9
(23.4–26.8) kg/m², and RP duration of 7.0 (2.5–14.3) years. Five patients
suffered from primary RP, and three patients had RP secondary to con-
nective tissue disease (CTD) [mixed CTD (n=2) and limited cutaneous
systemic sclerosis (n=1)]. All patients were very satisfied with the results
and the number of attacks in the left hand decreased (p=0.018). After
surgery an unilateral improvement in left hand perfusion was observed
Scientific Abstracts Saturday, 15 June 2019 1227
 on S
eptem









is: first published as 10.1136/annrheum
dis-2019-eular.8207 on 27 June 2019. D
ow
nloaded from
 
